Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction

Atherosclerosis

Volumn 140, Issue 1, 1998, Pages 155-159

  Joven, Jorge ^a   Simó, José M ^a   Vilella, Elisabet ^a   Camps, Jordi ^a   Masana, Luis ^a   De Febrer, Gabriel ^a   Camprubí, Mercè ^a   Richart, Cristobal ^b   Bardaji, Alfredo ^b   Casao, Elena ^c   Pocovi, Miguel ^c   Civeira, Fernando ^c  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c Departamentos de Bioquim Biol M   (Spain)

Author keywords

Aging; Coronary disease; Lipoproteins; Myocardial infarction; Platelets

Indexed keywords

APOLIPOPROTEIN E; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIIA; LIPOPROTEIN A;

ADULT; AGING; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY RISK; GENE FREQUENCY; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ADULT; ALLELES; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0032171435     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00076-8     Document Type: Article

References (40)

1. George JN, Nurden AT, Phillips DR Molecular defects in interactions of platelets with the vessel wall. New Engl J Med. 311:1984;1084.
2. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA Platelet activation in unstable coronary artery disease. New Engl J Med. 315:1986;983.
3. Fuster V, Badimon L, Badimon JJ, Chesebro JH The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl J Med. 326:1992;242.
4. Schrör K Antiplatelet drugs. A comparative review. Drugs. 50:1995;7.
5. The EPIC Investigators Use of a monoclonal antibody directed against the platelet glycoprotein IIb-IIIa receptor in high risk coronary angioplasty. New Engl J Med. 330:1994;956.
6. Kunicki TJ, Newman PJ The molecular biology of human platelet proteins. Blood. 80:1992;1396.
7. Weiss ET, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldsmith-Clermont PJ A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New Engl J Med. 334:1996;1090.
8. Nurden AT Polymorphisms of platelet receptors as risk factors in coronary thrombosis. Eur Heart J. 17:1996;1293.
9. A polymorphism and myocardial infarction (letter). New Engl J Med. 335:1996;1071.
10. A polymorphism and myocardial infarction (letter). New Engl J Med. 335:1996;1072.
11. Osborn SV, Hampton KK, Smillie D, Channer KS, Daly ME Platelet glycoprotein IIIa gene polymorphism and myocardial infarction (letter). Lancet. 348:1996;1309.
12. Carter AM, Gerning NO, Grant PJ Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction. Lancet. 348:1996;485.
13. A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 349:1997;385.
14. Davignon J, Gregg RE, Sing CF Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1.
15. Singer DRJ, Missouris CG, Jeffery S Angiotensin-converting enzyme gene polymorphism: what to do about all the confusion? Circulation. 94:1996;236.
16. Lander ES, Schork NJ Genetic dissection of complex traits. Science. 265:1994;2037.
17. Hixson JE and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb 1991;11:1237.
18. Scanu AM Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. J Lab Clin Med. 116:1990;142.
19. Ezratty A, Simon DI, Loscalzo J Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry. 32:1993;4628.
20. Malle E, Ibovnik A, Steinmetz A, Kostner GM, Sattler W Identification of glycoprotein IIB as the lipoprotein(a)-binding protein on platelets. Arterioscler Thromb. 14:1994;345.
21. Tunstall H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Circulation. 90:1994;583.
22. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature: nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607.
23. Miller SA, Dykes DD, Plesky HF A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16:1988;1215.
24. Jin Y, Dietz HC, Nurden A, Bray PF Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood. 82:1993;2281.
25. Civeira F, Pocovi M, Cenarro A, Casao E, Vilella E, Joven J, González J, García AL, Ordovás JM Apo E variants in patients with type III hyperlipoproteinemia. Atherosclerosis. 127:1996;273.
26. Simó J, Bertran N, Juanpere M, Camps J, Joven J Evaluación preliminar del analizador automático Monarch 2000. Quim Clin. 8:1989;329.
27. Joven J, Simó J, Vilella E, Camps J, Espinel E, Villabona C Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria. Clin Chem. 41:1995;908.
28. Matas C, Cabré M, La Ville A, Prats E, Joven J, Turner PR, Masana L, Camps J Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease. Clin Chem. 40:1994;404.
29. Emery AEH. Hardy-Weinberg equilibrium: the estimation of gene frequencies. In: Emery AEH, editor. Methodology in Medical Genetics: An Introduction to Statistical Methods. Edinburgh, UK: Churchill Livingstone, 1976: 3.
30. DeMeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI Genetic variation in lipoprotein(a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus. Am J Hum Genet. 56:1995;287-295.
31. Kamboh MI, Evans RW, Aston CE Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. Atherosclerosis. 117:1995;73-81.
32. Seed M, Hopplicher F, Reaveley D, McCarthy S, Thompson GR, Boerwinckle E, Utermann G Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. New Engl J Med. 322:1990;1494-1499.
33. Mbewu AD, Bhatnagar D, Durrington PN, Hunt L, Ishola M, Arrol S, Mackness M, Lockley P, Miller JP Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives and unrelated control populations. Arterioscler Thromb. 11:1991;940-946.
34. Hegele RA, Breckenridge WC, Brunt JH, Connelly PW Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration. Arterioscler Thromb Vasc Biol. 17:1997;1701-1706.
35. Uterman G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 80:1987;458.
36. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW Elevated serum lipoprotein(a) level is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 91:1995;1403.
37. Ryan MJ, Emig LL, Hicks GW, Ramharack R, Spahr MA, Kreick JS, Brammer DW, Chien AJ, Keiser JA Localization of lipoprotein(a) in a monkey model of rapid neointimal growth. Arterioscler Thromb Vasc Biol. 17:1997;181.
38. Miles LA, Fless GM, Scanu AM, Baynham P, Sebald MT, Skocir P, Curtis LK, Levin EG, Hoover-Plow JL, Plow EF Interaction of Lp(a) with plasminogen binding sites on cells. Thromb Haemost. 73:1995;458.
39. Schafer AI, Adelman B Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest. 75:1985;456.
40. Loscalzo J, Vaughan DE Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest. 79:1987;1749.